Do GLP-1 drugs cause muscle loss on their own?
Yes, GLP-1 receptor agonists (like semaglutide and liraglutide) can reduce lean body mass — including muscle — during weight loss. This is a known concern because losing muscle can lead to weakness, falls, and a condition called sarcopenia, especially in older adults. One study of elderly obese patients found that those taking semaglutide lost an average of 1.6 kg of lean mass over 16 weeks, even with a standard weight-loss program [3]. A 2026 review specifically warns that muscle loss with these drugs is common and raises the risk of sarcopenic obesity — where a person has both excess fat and too little muscle [5].
Can protein and exercise prevent that muscle loss?
Yes, the evidence strongly suggests that combining higher protein intake with strength (resistance) training can protect or even prevent muscle loss while on GLP-1s. In a 12-week study of 53 patients with type 2 diabetes on GLP-1s, those who followed a structured program with increased protein (1–1.5 g per kg of body weight per day) and 360 minutes of weekly exercise (with emphasis on strength training) lost no fat-free mass — while a comparison group not on GLP-1s lost 1.4 kg of muscle [1]. This suggests the protein-and-exercise combo offset the muscle-wasting effect of the drug.
The amount of protein matters. A large meta-analysis of 82 trials found that muscle strength gains from resistance training increase with total daily protein intake up to about 1.5 g per kg of body weight, but no further benefit beyond that [2]. Another study in young women showed that resistance training produced better muscle growth only when protein intake exceeded 1.5 g/kg/day [4]. For older adults specifically, a 2026 review recommends 1.2–1.6 g/kg/day of protein along with resistance exercise to preserve muscle mass and function during GLP-1 therapy [5].
Who is most at risk, and what should they do?
Older adults (65+) are at highest risk because aging itself causes muscle loss, and GLP-1 drugs can accelerate it. The 2026 review highlights that sarcopenia and sarcopenic obesity are major concerns in this group, and that tailored resistance exercise plus adequate protein (1.2–1.6 g/kg/day) is the recommended strategy [5]. The elderly study also found that semaglutide plus a standard program still led to some lean mass loss (1.6 kg), suggesting that older patients may need even more aggressive protein and exercise support [3].
For younger adults, the risk is lower but not zero. The meta-analysis [2] and the young-women study [4] both show that protein and resistance training work together to build and preserve muscle — so even if you're not elderly, relying on diet alone while on GLP-1s could leave you weaker over time. The practical takeaway: if you're prescribed a GLP-1 drug, ask your doctor about a plan that includes at least 1.2–1.5 g of protein per kg of body weight daily and regular strength training (2–3 times per week).
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2022 to 2026, 4 from 2024 or later, 3 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 50 papers retrieved from a database of over 500 million.
Sources used in this answer
14-PUB: The Effect of Structured Intensive Lifestyle Intervention on Muscle Mass in Patients with Type 2 Diabetes Receiving GLP-1 Receptor Agonists
In a 12-week study of 53 patients with type 2 diabetes on GLP-1s, those who followed a structured program with increased protein (1–1.5 g/kg body weight) and strength-focused exercise (360 min/week) lost no fat-free mass, while a comparison group not on GLP-1s lost 1.4 kg of muscle [1].
Synergistic Effect of Increased Total Protein Intake and Strength Training on Muscle Strength: A Dose-Response Meta-analysis of Randomized Controlled Trials
A meta-analysis of 82 trials found that protein supplementation only improves muscle strength when combined with resistance training; the optimal daily protein intake for strength gains is up to 1.5 g/kg body weight, with no further benefit above that [2].
12608 Preserving Lean Body Mass During Weight Loss In Elderly Obese Patients With Glp-1 Receptor Agonist Treatment
In a 16-week pilot study of 16 elderly obese patients, adding semaglutide to a standard weight-loss program led to 8.1 kg total weight loss, including 1.6 kg of lean mass loss, but the fat-to-lean ratio improved significantly compared to the control group [3].
Resistance training volume and nutrient intake on lean mass and strength in young women
In a 16-week resistance training study of 45 young women, muscle hypertrophy was significantly greater only when protein intake exceeded 1.5 g/kg/day, and strength gains required adequate energy intake (35–45 kcal/kg) alongside high training volume [4].
GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity.
A 2026 scoping review of GLP-1s in older adults concludes that muscle loss is common with these drugs and recommends combining them with resistance exercise and protein intake of 1.2–1.6 g/kg/day to preserve muscle mass and function [5].